Can exercise tests reveal hidden health risks in mental illness?
NCT ID NCT07306468
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study is measuring how well people with schizophrenia or bipolar disorder can exercise, breathe, and manage daily life. Researchers will test lung function, breathing muscle strength, and walking ability in 150 adults. The goal is to find physical limitations that could be improved with better rehabilitation programs.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this study could point toward better rehabilitation programs that improve physical health and quality of life for people with severe mental illness.
- What could go wrong
- This is an observational study, not a treatment trial, so it won't directly change patient care. Results may not apply to everyone with these conditions.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BIPOLAR DISORDER (BD) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Çankırı Karatekin University, Faculty of Health Sciences, Department of Physiotherapy and Rehabilitation
RECRUITINGÇankırı, Çankırı, 18100, Turkey (Türkiye)
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can the immune system hold the key to treating resistant mental illness?
- Gold nanoparticles may make lithium therapy safer and more effective
- Talking back to stigma: can psychoeducation ease the hidden burden of bipolar disorder?
- Can a short exercise program stop antipsychotic weight gain?
- Targeted magnetic pulses aim to lift bipolar depression
- New hope for bipolar depression? pramipexole trial targets anhedonia